Acupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.

NANot yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Hot FlashesBreast CancerAcupuncture
Interventions
OTHER

Acupuncture treatment

"Acupoint selection: Hegu-Yinxi acupoint group (clearing heat and relieving sweat), Sanyinjiao-Fuliu acupoint group (nourishing yin and tonifying kidney), Tianshu-uteri acupoint group (special effect points) (12 acupoints on both sides).~Frequency: 3 times a week (once every other day) for a total of 8 weeks of continuous treatment.~Operation: Use a one-time sterile acupuncture needle (0.30×40mm, Huatuo brand), insert the needle 0.5 inch along the anatomical position, level up and relieve the qi, and keep the needle for 20 minutes."

OTHER

Sham Acupuncture treatment

"Selecting acupoints: Select the side opening positions of the 6 acupuncture points in the real acupuncture group, and select non-meridian and non-points (points with less nerve distribution, sparseness, and rich muscles).~Frequency: 3 times a week (once every other day) for a total of 8 weeks of continuous treatment.~Operation: ① Shallow needling scheme: use a disposable sterile acupuncture needle, insert the needle 0.2 inch, without twisting, and keep the needle for 20 minutes. ②Non-invasive acupuncture plan: choose a special comfort needle with no needle tip at the top of the needle, paste a disposable sterile foam pad on the non-acupoint, and use a disposable sterile flat head The acupuncture needles were pierced into the foam pad, lightly touching but not piercing the skin, and not breathing; the needles were kept for 20 minutes."

Trial Locations (1)

210029

Jiangsu Province Hospital of Traditional Chinese Medcine, Nanjing

All Listed Sponsors
collaborator

Xi'an Jiaotong University

OTHER

lead

Nanjing University of Traditional Chinese Medicine

OTHER

NCT05460819 - Acupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer. | Biotech Hunter | Biotech Hunter